78.91 0.00 (0.00%)
After hours: 4:09PM EDT
|Bid||77.07 x 900|
|Ask||90.00 x 800|
|Day's Range||78.61 - 80.95|
|52 Week Range||45.88 - 82.39|
|Beta (3Y Monthly)||1.62|
|PE Ratio (TTM)||33.46|
|Earnings Date||Nov 1, 2018 - Nov 2, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||80.80|
Medpace (MEDP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Teladoc's (TDOC) vast business presence in the growing telehealth industry with many deal wins and international expansion should drive long-term growth.
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a...
The Zacks Analyst Blog Highlights: Industrial Logistics, Medpace, Unitil, DaVita and Telephone and Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 30) Acasti Pharma Inc (NASDAQ: ACST ) ANI Pharmaceuticals ...
Medpace stock leaped more than 15% this morning, following the Madisonville-based firm’s reported second quarter earnings on Monday afternoon. Medpace's stock closed Tuesday at $79.91, up $11.9 for the day, or nearly 18%. Medpace, which conducts clinical trials for companies worldwide that want to bring new drugs and medical devices to market (Nasdaq: MEDP), reported revenue of $214.1 million for the quarter that ended in June.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 29) Acasti Pharma Inc (NASDAQ: ACST ) Array Biopharma Inc ...
Medpace (MEDP) delivered earnings and revenue surprises of 28.57% and 6.72%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
CINCINNATI-- -- Revenue of $214.1 million in the second quarter of 2019 increased 25.8% from revenue of $170.1 million for the comparable prior-year period, representing a backlog conversion rate of 19.3%. Net new business awards were $279.2 million in the second quarter of 2019, representing an increase of 16.4% from net new business awards of $239.9 million for the comparable prior-year period, which ...
Biotech stocks moved mostly sideways during the week, although there was a flurry of activity in the space. Earnings from the sector began to trickle in, with Bristol-Myers Squibb Co (NYSE: BMY ) reporting ...
Medpace (MEDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Medpace (MEDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
A stock that more than quadrupled in the first half of 2019 shot a Cincinnati investment adviser to an enormous lead at the halfway point of the Courier’s annual stock-picking contest.
The Business Courier analyzed Greater Cincinnati's 25 locally based public companies to see which CEOs gave their shareholders the best value for the money.
Medpace Holdings, Inc. today announced that it will report its second quarter 2019 financial results after the market close on Monday, July 29, 2019. The Company will host a conference call the following morning, Tuesday, July 30, 2019, at 9:00 a.m.
Medpace Holdings Inc NASDAQ/NGS:MEDPView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for MEDP with between 5 and 10% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, growth of ETFs holding MEDP is favorable, with net inflows of $1.64 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.